Norbornene polymerization using the commercially available and inexpensive catalyst system, cyclopentadienylzirconium trichloride (CpZrCl3) and isobutyl‐modified methylaluminoxane (MMAO), were carried out over a wide range of polymerization temperatures and monomer concentrations. For the CpZrCl3 catalyst system activated by aluminoxane with a 40 mol % methyl group and a 60 mol % isobutyl group (MMAO40/60), the polymerization temperature and monomer concentration significantly affected the molecular weight (Mn) of the obtained polymer and the catalytic activity. With an increase in the polymerization temperature from 0 to 27 °C, the catalytic activity and Mn increased, but these values dramatically decreased with the increasing polymerization temperature from 27 to 70 °C, meaning that the most suitable temperature was 27 °C. The CpZrCl3/MMAO40/60 ([Al]/[Zr] = 1000) catalyst system with the [NB] of 2.76 mol L−1 at 27 °C showed the highest activity of 145 kg molZr−1 h−1 and molecular weight of 211,000 g mol−1. The polymerization using the CpZrCl3/MMAO40/60 catalyst system proceeds through the vinyl addition mechanism to produce atactic polynorbornene, which was soluble in chloroform, toluene, and 1,2‐dichlorobenzene, but insoluble in methanol.
No takes yet. Share an insight, caveat, or question.
Nishizawa et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: